Nevro Corp Stock News

Nevro Corp (NYSE:NVRO)’s share price fell 0.6% during mid-day trading on Monday . The company traded as low as $68.06 and last traded at $70.18, 382,750 shares traded hands during trading. A decline

Envestnet Asset Management Inc. decreased its stake in shares of Nevro Corp (NYSE:NVRO) by 72.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,659 sh

Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.

Bank of Montreal Can increased its position in shares of Nevro Corp (NYSE:NVRO) by 44.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned

ArrowMark Colorado Holdings LLC lessened its stake in Nevro Corp (NYSE:NVRO) by 4.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional i

It certainly might concern Nevro Corp. (NYSE:NVRO) shareholders to see the share price down 37% in just 30 days. While...

Blair William & Co. IL reduced its stake in Nevro Corp (NYSE:NVRO) by 11.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The

Below is the February 2020 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG)

The "Neuromodulation Market by Technology - Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation), Application (Ischemia, Chronic Pain, Parkinson's,

Nevro Corp (NYSE:NVRO) dropped 7.8% on Wednesday . The company traded as low as $106.61 and last traded at $109.82, approximately 893,485 shares traded hands during mid-day trading. An increase of 105

Nevro (NVRO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Nevro (NVRO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.